Editas Medicine EDIT
NASDAQ EDIT
$2.37 -0.12 (-4.82%)
As of: Oct 23, 2026 · 2:12 PM EDT

Editas Medicine (EDIT) Gains from Investment Securities (2020)

Updated

Analysis

Editas Medicine (EDIT) Gains from Investment Securities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Editas Medicine 212.61 Mn -499.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 3.26 Mn
Sep 30, 2020 -1.42 Mn
Jun 30, 2020 7.19 Mn
Mar 31, 2020 7.33 Mn
API Access

Editas Medicine Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=EDIT&period=max&api_key=YOUR_API_KEY